ACE2 and pulmonary arterial hypertension: SARS-CoV-2 binding to ACE2 leads to down-regulation of ACE2 expression, disrupting the balance of the RAS system, exacerbating lung injury and contribute to the pathogenesis of pulmonary hypertension and insufficiency.